Average peak sales forecast per new biopharmaceutical asset 2013-2022
This statistic shows the projected average peak sales per new pharmaceutical pipeline asset from 2013 to 2022, in million U.S. dollars.The projected average peak sales per new asset dropped from 517 million U.S. dollars in 2021 to 405 million U.S. dollars in 2022.